Tag: dual incretin therapy

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works and What to Expect
Tirzepatide for Weight Loss: How Dual Incretin Therapy Works and What to Expect
Jan, 18 2026 Health and Wellness Caspian Lockhart
Tirzepatide (Zepbound) is the first dual incretin therapy approved for weight loss, targeting both GLP-1 and GIP receptors to deliver up to 22.4% body weight loss. Learn how it works, what to expect, and how it compares to other weight-loss drugs.